PHARMACOKINETIC/PHARMACODYNAMIC RELATHIONSHIP AND SIMULATION ANALYSIS FOR THE EVALUATION OF ISONIAZID HEPATOTOXICITY RICK DEVELOPMENT IN PATIENTS WITH TUBERCOLOSIS.